search
Back to results

Effects of Blocking Blue Light at Night Post CABG, AVR, MVR, CABG AVR, CABG MVR, or SAH

Primary Purpose

Circadian Rhythm Disorders

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Blue light-blocking goggles
Clear goggles
Sponsored by
West Virginia University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Circadian Rhythm Disorders focused on measuring CABG, coronary artery bypass graft, light at night, dim light at night, inflammation, cognition, blue light

Eligibility Criteria

45 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Both men and women that are undergoing elective (non-emergency)

    • on-pump CABG surgery,
    • AVR,
    • MVR,
    • CABG AVR,
    • CABG MVR or
    • SAH
  • No history of diagnosed psychiatric disorders or organ failure

Exclusion Criteria:

  • Evidence or diagnosis of dementia or other cognitive deficit
  • Diagnosed psychiatric disorder (including depression and anxiety)
  • Organ failure [kidney (creatine > 1.5 mg/dL), liver, etc.]
  • Chronic obstructive pulmonary disease,
  • Any immune disorder
  • Acute infection
  • Prior cardiac surgery
  • Elective aneurysms
  • Combined cardiac operations
  • Left main stenosis greater than 70%
  • Left ventricular ejection fraction (LVEF) lower than 0.5
  • Any condition that increases likelihood of the need for a blood transfusion during or after the surgery
  • Clotting disorder
  • Suspected less than 8th grade English reading comprehension level

Sites / Locations

  • West Virginia University Heart and Vascular InstituteRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Placebo Comparator

Experimental

Arm Label

Clear goggles

Blue-light blocking goggles

Arm Description

Patients recovering from CABG, AVR, MVR, CABG AVR, CABG MVR, or SAH surgery will be given clear goggles to wear at nighttime.

Patients recovering from CABG, AVR, MVR, CABG AVR, CABG MVR, or SAH surgery will be given blue-light blocking goggles to wear at nighttime.

Outcomes

Primary Outcome Measures

Change in baseline serum cytokine profile
Assessed via an immuno multiplex panel for the following cytokines:TNF-α, IL-1β, IL-6, IL-2, and IL-8. Units of measure for all cytokines are pg/mL.
Change in baseline serum cytokine profile
Assessed via an immuno multiplex panel for the following cytokines:TNF-α, IL-1β, IL-6, IL-2, and IL-8. Units of measure for all cytokines are pg/mL.
Change in baseline serum cardiac ischemia profile
Assessed via an immuno multiplex panel for the following indicators of ischemia: CRP, BNP, NT-proBNP, cardiac troponin T, and CK-MB. Units of measure for all indicators of ischemia are pg/mL.
Change in baseline serum cardiac ischemia profile
Assessed via an immuno multiplex panel for the following indicators of ischemia: CRP, BNP, NT-proBNP, cardiac troponin T, and CK-MB. Units of measure for all indicators of ischemia are pg/mL.
Change in baseline mood (Hamilton Depression Scale)
Hamilton Depression Scale questionnaire. Scores between 0 - 54, with increasing scores indicating severity of depression.
Change in baseline mood (Hamilton Depression Scale)
Hamilton Depression Scale questionnaire. Scores between 0 - 54, with increasing scores indicating severity of depression.
Change in baseline sleep (PSQI)
Pittsburgh Sleep Quality Index survey. Scores between 0 - 21, a greater score is worse sleep/more impairment.
Change in baseline sleep (PSQI)
Pittsburgh Sleep Quality Index (PSQI) survey. Scores between 0 - 21, a greater score is worse sleep/more impairment.
Change in baseline central executive cognitive function (Trail Making Test (part B))
Trail Making Test (part B) TMT B are reported as the number of seconds required to complete the task; therefore, higher scores reveal greater impairment.
Change in baseline central executive cognitive function (Trail Making Test (part B))
Trail Making Test (part B) TMT B are reported as the number of seconds required to complete the task; therefore, higher scores reveal greater impairment.
Change in baseline cognitive function (WAIS-R)
Wechsler Adult Intelligence Scale-Revised (WAIS-R). Scores vary between subtests, but are on a scale between 0 - 135; a higher score indicates better performance.
Change in baseline cognitive function (WAIS-R)
Wechsler Adult Intelligence Scale-Revised (WAIS-R). Scores vary between subtests, but are on a scale between 0 - 135; a higher score indicates better performance.

Secondary Outcome Measures

Full Information

First Posted
July 21, 2020
Last Updated
November 1, 2022
Sponsor
West Virginia University
search

1. Study Identification

Unique Protocol Identification Number
NCT04578249
Brief Title
Effects of Blocking Blue Light at Night Post CABG, AVR, MVR, CABG AVR, CABG MVR, or SAH
Official Title
Effects of Blocking Blue Light at Night on Patient Outcomes After Elective CABG, AVR, MVR, CABG AVR, CABG MVR, or SAH
Study Type
Interventional

2. Study Status

Record Verification Date
November 2022
Overall Recruitment Status
Recruiting
Study Start Date
September 20, 2021 (Actual)
Primary Completion Date
March 2025 (Anticipated)
Study Completion Date
March 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
West Virginia University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Purpose The purpose of this study is to determine whether filtering out blue light at nighttime reduces post-surgical inflammation and/or moderates cognitive decline and mood and sleep alterations in patients undergoing elective CABG, AVR, MVR, CABG AVR, CABG MVR, or SAH surgery. If manipulating nighttime light in hospital rooms improves patient outcomes, then it would be a relatively easy and inexpensive innovation that could reduce post-surgical complications and save millions of dollars per year in health care costs by shortening the length of hospital stays and reducing morbidity. The investigators aim to determine the relationship between inflammation and cognitive dysfunction after cardiac surgery.
Detailed Description
Cardiovascular disease is the leading cause of death in the US. Each year, more than 500,000 coronary revascularization surgeries are performed. The in-hospital mortality rate among patients undergoing coronary artery bypass graft (CABG) surgery has declined to less than 6% in recent years, but potentially serious complications still occur and can prolong hospitalization, impair quality of life, and substantially increase medical costs. Excessive postsurgical inflammation can contribute to adverse outcomes, and the investigators hypothesize that exposure of patients to extraneous light at night during in-hospital recovery potentiates the inflammatory response to Coronary artery bypass graft (CABG), aortic valve replacement (aAVR), mitral valve replacement (MVR), CABG with aortic valve replacement (CABG AVR), or CABG with mitral valve replacement (CABG MVR), in turn, compromising several aspects of recovery. This hypothesis is based on our mouse models of brief global and focal cerebral ischemia; mice exposed to dim light at night (dLAN) during ischemic recovery have substantially more inflammation, neurological damage, and functional deficits than mice exposed to dark nights during ischemic recovery. The circadian system of mammals, including mice and humans, is most sensitive to light within the blue range of the spectrum (450- 485 nm); substituting longer wavelength light for nighttime exposures of mice recovering from ischemia eliminates the detrimental effects of the exposure to light at night (LAN). Based on these data, the hypothesis is that filtering the light CABG, AVR, MVR, CABG AVR, CABG MVR, or SAH surgery patients are exposed to at night during in-hospital recovery will reduce inflammation, and in turn improve functional outcome. Specific Goals To determine if exposure of patients to extraneous LAN during recovery in the hospital potentiates the post- surgical inflammatory response. In the proposed study, consenting patients undergoing elective CABG, AVR, MVR, CABG AVR, CABG MVR, or SAH surgery will be randomly assigned to (1) the control group which will wear goggles for 10h at night that allow the full spectrum of light to pass through or to (2) the experimental group which will wear goggles for 10h at night that filter out wavelengths of light between 450-485 nm (i.e. the part of the spectrum that activates photosensitive ganglion cells and alters entrainment of the circadian clock). Baseline and postsurgical measures of inflammation and cognitive function will be obtained prior to surgery and during recovery in the hospital. If exposure to short wavelength (blue) LAN increases post-cardiac surgery inflammation, then the experimental group with filtered goggles will have lower blood markers of inflammation than the control group. Furthermore, we predict that reduced inflammation among the experimental group will be associated with less severe cognitive deficits on post-surgical day 5 (typically the day before discharge). In summary, this project will determine whether night-time exposure to blue light while recovering from CABG, AVR, MVR, CABG AVR, CABG MVR, or SAH surgery in the hospital affects the post-surgical inflammatory response and outcome. This study is innovative in two regards: 1) it will the first study to determine how a factor of a hospital's physical environment influences recovery from a major surgery and 2) it will be the first CABG study to determine whether reduction of early post-operative inflammation improves heart function and cognitive function after surgery. Elevated post- surgical inflammation is associated with a wide range of negative outcomes. If LAN exposure in the hospital does increase post-surgical inflammation, then adjusting patient exposure to environmental lighting could prove to be an inexpensive and effective way to improve patient outcome for CABG, AVR, MVR, CABG AVR, CABG MVR, or SAH surgery and a wide range of medical conditions that have an inflammatory component. In summary, the proposed study will determine whether exposure to extraneous LAN exacerbates inflammation and compromises recovery from CABG, AVR, MVR, CABG AVR, CABG MVR, or SAH surgery. Our preliminary data indicated that cardiovascular patients are exposed to extraneous light several times per night while staying in the hospital and that LAN is associated with increased inflammation in both diurnal and nocturnal rodents [15]. The proposed project represents a "first step" aimed at determining whether hospital lighting affects inflammation. However, the payoff could be enormous; if manipulating nighttime light in hospital rooms improves patient outcomes, then it would be a relatively easy, inexpensive, innovation that could reduce post-surgical complications and save millions of dollars per year in health care costs by shortening the length of hospital stays and reducing morbidity.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Circadian Rhythm Disorders
Keywords
CABG, coronary artery bypass graft, light at night, dim light at night, inflammation, cognition, blue light

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Study participants at the Heart and Vascular Institute (HVI) will be randomly assigned to the control group (goggles that allow through the full spectrum of light), or to the experimental group (goggles that filter out light in the blue range) using block randomization. With a sample size of 40 participants per group (i.e., N = 80 total).
Masking
None (Open Label)
Allocation
Randomized
Enrollment
80 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Clear goggles
Arm Type
Placebo Comparator
Arm Description
Patients recovering from CABG, AVR, MVR, CABG AVR, CABG MVR, or SAH surgery will be given clear goggles to wear at nighttime.
Arm Title
Blue-light blocking goggles
Arm Type
Experimental
Arm Description
Patients recovering from CABG, AVR, MVR, CABG AVR, CABG MVR, or SAH surgery will be given blue-light blocking goggles to wear at nighttime.
Intervention Type
Other
Intervention Name(s)
Blue light-blocking goggles
Other Intervention Name(s)
Uvex (Honeywell, USA)
Intervention Description
Participants will be randomly assigned to one of the two intervention groups.
Intervention Type
Other
Intervention Name(s)
Clear goggles
Other Intervention Name(s)
Uvex (Honeywell, USA)
Intervention Description
Participants will be randomly assigned to one of the two intervention groups.
Primary Outcome Measure Information:
Title
Change in baseline serum cytokine profile
Description
Assessed via an immuno multiplex panel for the following cytokines:TNF-α, IL-1β, IL-6, IL-2, and IL-8. Units of measure for all cytokines are pg/mL.
Time Frame
5 days post-surgery
Title
Change in baseline serum cytokine profile
Description
Assessed via an immuno multiplex panel for the following cytokines:TNF-α, IL-1β, IL-6, IL-2, and IL-8. Units of measure for all cytokines are pg/mL.
Time Frame
30 days post-surgery
Title
Change in baseline serum cardiac ischemia profile
Description
Assessed via an immuno multiplex panel for the following indicators of ischemia: CRP, BNP, NT-proBNP, cardiac troponin T, and CK-MB. Units of measure for all indicators of ischemia are pg/mL.
Time Frame
5 days post-surgery
Title
Change in baseline serum cardiac ischemia profile
Description
Assessed via an immuno multiplex panel for the following indicators of ischemia: CRP, BNP, NT-proBNP, cardiac troponin T, and CK-MB. Units of measure for all indicators of ischemia are pg/mL.
Time Frame
30 days post-surgery
Title
Change in baseline mood (Hamilton Depression Scale)
Description
Hamilton Depression Scale questionnaire. Scores between 0 - 54, with increasing scores indicating severity of depression.
Time Frame
5 days post-surgery
Title
Change in baseline mood (Hamilton Depression Scale)
Description
Hamilton Depression Scale questionnaire. Scores between 0 - 54, with increasing scores indicating severity of depression.
Time Frame
30 days post-surgery
Title
Change in baseline sleep (PSQI)
Description
Pittsburgh Sleep Quality Index survey. Scores between 0 - 21, a greater score is worse sleep/more impairment.
Time Frame
5 days post-surgery
Title
Change in baseline sleep (PSQI)
Description
Pittsburgh Sleep Quality Index (PSQI) survey. Scores between 0 - 21, a greater score is worse sleep/more impairment.
Time Frame
30 days post-surgery
Title
Change in baseline central executive cognitive function (Trail Making Test (part B))
Description
Trail Making Test (part B) TMT B are reported as the number of seconds required to complete the task; therefore, higher scores reveal greater impairment.
Time Frame
5 days post-surgery
Title
Change in baseline central executive cognitive function (Trail Making Test (part B))
Description
Trail Making Test (part B) TMT B are reported as the number of seconds required to complete the task; therefore, higher scores reveal greater impairment.
Time Frame
30 days post-surgery
Title
Change in baseline cognitive function (WAIS-R)
Description
Wechsler Adult Intelligence Scale-Revised (WAIS-R). Scores vary between subtests, but are on a scale between 0 - 135; a higher score indicates better performance.
Time Frame
5 days post-surgery
Title
Change in baseline cognitive function (WAIS-R)
Description
Wechsler Adult Intelligence Scale-Revised (WAIS-R). Scores vary between subtests, but are on a scale between 0 - 135; a higher score indicates better performance.
Time Frame
30 days post-surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
45 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Both men and women that are undergoing elective (non-emergency) on-pump CABG surgery, AVR, MVR, CABG AVR, CABG MVR or SAH No history of diagnosed psychiatric disorders or organ failure Exclusion Criteria: Evidence or diagnosis of dementia or other cognitive deficit Diagnosed psychiatric disorder (including depression and anxiety) Organ failure [kidney (creatine > 1.5 mg/dL), liver, etc.] Chronic obstructive pulmonary disease, Any immune disorder Acute infection Prior cardiac surgery Elective aneurysms Combined cardiac operations Left main stenosis greater than 70% Left ventricular ejection fraction (LVEF) lower than 0.5 Any condition that increases likelihood of the need for a blood transfusion during or after the surgery Clotting disorder Suspected less than 8th grade English reading comprehension level
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
James C Walton, PhD
Phone
3042933490
Email
james.walton@hsc.wvu.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Olga H Meléndez-Fernández, BS
Phone
3042930272
Email
ohm0001@mix.wvu.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Randy J Nelson, PhD
Organizational Affiliation
West Virginia University
Official's Role
Principal Investigator
Facility Information:
Facility Name
West Virginia University Heart and Vascular Institute
City
Morgantown
State/Province
West Virginia
ZIP/Postal Code
26506
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
James C. Walton, PhD
Phone
304-293-3490
Email
james.walton@hsc.wvu.edu
First Name & Middle Initial & Last Name & Degree
Olga H Meléndez-Fernández, BS
Phone
3042930272
Email
ohm0001@mix.wvu.edu

12. IPD Sharing Statement

Citations:
PubMed Identifier
7733754
Citation
Murkin JM, Newman SP, Stump DA, Blumenthal JA. Statement of consensus on assessment of neurobehavioral outcomes after cardiac surgery. Ann Thorac Surg. 1995 May;59(5):1289-95. doi: 10.1016/0003-4975(95)00106-u. No abstract available.
Results Reference
background
PubMed Identifier
2240918
Citation
Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990 Dec 15;113(12):941-8. doi: 10.7326/0003-4819-113-12-941.
Results Reference
background
PubMed Identifier
21929528
Citation
Joyeux-Faure M, Durand M, Bedague D, Protar D, Incagnoli P, Paris A, Ribuot C, Levy P, Chavanon O. Evaluation of the effect of one large dose of erythropoietin against cardiac and cerebral ischemic injury occurring during cardiac surgery with cardiopulmonary bypass: a randomized double-blind placebo-controlled pilot study. Fundam Clin Pharmacol. 2012 Dec;26(6):761-70. doi: 10.1111/j.1472-8206.2011.00992.x. Epub 2011 Sep 20.
Results Reference
background
PubMed Identifier
18838601
Citation
Brainard GC, Sliney D, Hanifin JP, Glickman G, Byrne B, Greeson JM, Jasser S, Gerner E, Rollag MD. Sensitivity of the human circadian system to short-wavelength (420-nm) light. J Biol Rhythms. 2008 Oct;23(5):379-86. doi: 10.1177/0748730408323089.
Results Reference
background
PubMed Identifier
20599459
Citation
Sasseville A, Hebert M. Using blue-green light at night and blue-blockers during the day to improves adaptation to night work: a pilot study. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Oct 1;34(7):1236-42. doi: 10.1016/j.pnpbp.2010.06.027. Epub 2010 Jul 3.
Results Reference
background
PubMed Identifier
19637050
Citation
Sasseville A, Benhaberou-Brun D, Fontaine C, Charon MC, Hebert M. Wearing blue-blockers in the morning could improve sleep of workers on a permanent night schedule: a pilot study. Chronobiol Int. 2009 Jul;26(5):913-25. doi: 10.1080/07420520903044398.
Results Reference
background
PubMed Identifier
21902824
Citation
Figueiro MG, Lesniak NZ, Rea MS. Implications of controlled short-wavelength light exposure for sleep in older adults. BMC Res Notes. 2011 Sep 8;4:334. doi: 10.1186/1756-0500-4-334.
Results Reference
background
PubMed Identifier
11837952
Citation
Cole RJ, Smith JS, Alcala YC, Elliott JA, Kripke DF. Bright-light mask treatment of delayed sleep phase syndrome. J Biol Rhythms. 2002 Feb;17(1):89-101. doi: 10.1177/074873002129002366.
Results Reference
background
PubMed Identifier
17720383
Citation
Parolari A, Camera M, Alamanni F, Naliato M, Polvani GL, Agrifoglio M, Brambilla M, Biancardi C, Mussoni L, Biglioli P, Tremoli E. Systemic inflammation after on-pump and off-pump coronary bypass surgery: a one-month follow-up. Ann Thorac Surg. 2007 Sep;84(3):823-8. doi: 10.1016/j.athoracsur.2007.04.048.
Results Reference
background
PubMed Identifier
20444674
Citation
Clive Landis R, Murkin JM, Stump DA, Baker RA, Arrowsmith JE, De Somer F, Dain SL, Dobkowski WB, Ellis JE, Falter F, Fischer G, Hammon JW, Jonas RA, Kramer RS, Likosky DS, Paget Milsom F, Poullis M, Verrier ED, Walley K, Westaby S. Consensus statement: minimal criteria for reporting the systemic inflammatory response to cardiopulmonary bypass. Heart Surg Forum. 2010 Apr;13(2):E116-23. doi: 10.1532/HSF98.20101022.
Results Reference
background
PubMed Identifier
20829070
Citation
Nozohoor S, Nilsson J, Algotsson L, Sjogren J. Postoperative increase in B-type natriuretic peptide levels predicts adverse outcome after cardiac surgery. J Cardiothorac Vasc Anesth. 2011 Jun;25(3):469-75. doi: 10.1053/j.jvca.2010.07.002. Epub 2010 Sep 9.
Results Reference
background
PubMed Identifier
19692262
Citation
Gasparovic H, Burcar I, Kopjar T, Vojkovic J, Gabelica R, Biocina B, Jelic I. NT-pro-BNP, but not C-reactive protein, is predictive of atrial fibrillation in patients undergoing coronary artery bypass surgery. Eur J Cardiothorac Surg. 2010 Jan;37(1):100-5. doi: 10.1016/j.ejcts.2009.07.003. Epub 2009 Aug 18.
Results Reference
background
PubMed Identifier
21304084
Citation
Domanski MJ, Mahaffey K, Hasselblad V, Brener SJ, Smith PK, Hillis G, Engoren M, Alexander JH, Levy JH, Chaitman BR, Broderick S, Mack MJ, Pieper KS, Farkouh ME. Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery. JAMA. 2011 Feb 9;305(6):585-91. doi: 10.1001/jama.2011.99.
Results Reference
background
PubMed Identifier
11235725
Citation
Westaby S, Saatvedt K, White S, Katsumata T, van Oeveren W, Halligan PW. Is there a relationship between cognitive dysfunction and systemic inflammatory response after cardiopulmonary bypass? Ann Thorac Surg. 2001 Feb;71(2):667-72. doi: 10.1016/s0003-4975(00)02405-x.
Results Reference
background
PubMed Identifier
22217098
Citation
Fonken LK, Haim A, Nelson RJ. Dim light at night increases immune function in Nile grass rats, a diurnal rodent. Chronobiol Int. 2012 Feb;29(1):26-34. doi: 10.3109/07420528.2011.635831. Erratum In: Chronobiol Int. 2012 May;29(4):530.
Results Reference
background

Learn more about this trial

Effects of Blocking Blue Light at Night Post CABG, AVR, MVR, CABG AVR, CABG MVR, or SAH

We'll reach out to this number within 24 hrs